2026³â 06¿ù 28ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 103598°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



LIG D&A-¶óÀθÞÅ», ÇÕÀÛȸ»ç ¼³¸³ ÃßÁø

À¯·´¡¤NATO ´ÙÃþ ¹æ°ø ü°è ±¸Ãà Çù·Â
LIG µðÆæ½º ¿¡¾î·Î½ºÆäÀ̽º(ÀÌÇÏ LIG D&A)¿Í ¶óÀθÞÅ» ¿¡¾îµðÆæ½º(ÀÌÇÏ ¶óÀθÞÅ»)°¡ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¸Î°í À¯·´ ¹× ³ªÅä(NATO)¿¡ ´ëÇÑ Ã·´Ü ¹æ°ø ½Ã½ºÅÛ °ø±ÞÀ» À§ÇØ Àü¹æÀ§Àû Çù·ÂÀ» ÃßÁøÇÑ´Ù. ¾ç»ç´Â À¯·´ ³» ´ÙÃþ ¹æ°ø ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ´Â »óȲ¿¡¼­ °í°´ ¿ä±¸¿¡ ºÎÇÕÇÏ´Â ÅëÇÕ ¹æ°ø ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇÑ Çù·Â ¹æ¾ÈÀ» ³íÀÇÇϰí ÀÖ´Ù. À̸¦ À§ÇÑ Ã¹ Çຸ·Î LIG¿Í ¶óÀθÞÅ» °£ÀÇ À¯·´ ³» ÇÕÀÛȸ»ç ¼³¸³°ú °ü·ÃÇÑ ³íÀǸ¦ ½Éµµ ÀÖ°Ô ÁøÇà ÁßÀÌ´Ù. À̹ø Çù·ÂÀ» ÅëÇØ ¾ç»ç´Â »óÈ£ º¸¿ÏÀûÀÎ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ±â¹ÝÀ¸·Î À¯·´ ...

¡®ÇÏÆ®½Ã±×³Î5¡¯ ÀÔÁÖÀÚ 8ÀÎ, ÀϺ» µµÄí½Ã¸¶·Î ¿©Çà ¶°³ª

¼³·½°ú ÁúÅõÀÇ ¼Ò¿ëµ¹ÀÌ ¿¹°í
‘ÇÏÆ®½Ã±×³Î5’ ÀÔÁÖÀÚ 8ÀÎÀÌ È¥µ·ÀÇ ·¯ºê¶óÀÎ ¼Ó ÀϺ» µµÄí½Ã¸¶·Î ¿©ÇàÀ» ¶°³­´Ù. 19ÀÏ(È­) ¹ã 10½Ã ¹æ¼ÛµÇ´Â ä³ÎA ‘ÇÏÆ®½Ã±×³Î5’(¿¬Ãâ ¹Úöȯ, ±èÈ«±¸) 6ȸ¿¡¼­´Â ‘½Ã±×³Î ÇϿ콺’ ÀÔÁÖÀÚ 8ÀÎ(¹Ú¿ì¿­-±è¼º¹Î-±è¼­¿ø-Á¤ÁØÇö-±è¹ÎÁÖ-Á¤±Ô¸®-°­À¯°æ-ÃÖ¼ÒÀ±)ÀÌ ÀϺ» µµÄí½Ã¸¶¿¡¼­ ¿©ÇàÀ» °âÇÑ µ¥ÀÌÆ®¸¦ ÇÏ¸ç º¹ÀâÇÑ °¨Á¤ÀÇ ¼Ò¿ëµ¹ÀÌ¿¡ ºüÁö´Â ¸ð½ÀÀÌ ´ã±ä´Ù. À̳¯ ÀϺ»¿¡ µµÂøÇÑ ÀÔÁÖÀÚµéÀº Â÷¸¦ Ÿ°í ¹Ù´å°¡·Î À̵¿ÇÑ´Ù. Â÷ ¾È¿¡¼­ °­À¯°æÀº ¹Ú¿ì¿­ÀÇ ¿·ÀÚ¸®¿¡ ¾É¾Æ ¹à°Ô ¿ô°í, Â÷°¡ Èçµé¸®ÀÚ ¹Ú ...

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its Firs...

Marks first launch in Japan through partnership with NIPRO CORPORATION.
INCHEON, KOREA -- Samsung Bioepis Co., Ltd. announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), marking its first product launch in Japan under partnership with NIPRO CORPORATION (hereafter “NIPRO”). The launch follows the Official Gazette announcement on May 19 regarding the product’s listing under the National Health Insurance (NHI) Drug Price Standard, which became effective tod ...
BeOne Medicines¡¯ Sonrotoclax Granted Breakthrough Therapy D... (2025-11-12)
¹Ì°Ç¶óÀÌÇÁ, Ȩ ÇコÄɾî Á¦Ç° ·»Å» ¼­ºñ½º ½ÃÀÛ (2024-07-21)
eM Client¡¯s Mobile App Generally Available with AI-Assisted... (2025-11-05)
Aster Guardians Global Nursing Award 2025 Worth US$250,000 N... (2024-12-27)
ÀüÇö¹«, ¡®13³â Áö±â¡¤13¼¼ ¿¬ÇÏ¡¯ À忹¿ø ¾Æ³ª¿î¼­¿Í ´Ü µÑÀÌ ... (2024-12-20)
±â¾Æ ŸÀ̰ÅÁî ¿ì½Â ±â³ä °í°´ ¸¸Á· À̺¥Æ® (2024-12-20)
Toshiba Releases 650V 3rd Generation SiC MOSFETs in TOLL Pac... (2025-09-17)
Çѱ¹°¡¾÷½Â°èÁøÈï¿ø, Áß¼Ò±â¾÷ Çõ½Å¹Ù¿ìó»ç¾÷ ¼öÇà±â°ü ¼±Á¤ (2024-11-22)
´ëÇÑÀü¼±, ½Ì°¡Æ÷¸£¼­ 1100¾ï ±Ô¸ð Ãʰí¾Ð ÅÏŰ ÇÁ·ÎÁ§Æ® ¼öÁÖ (2025-08-13)
¾×Ƽ¾ð vs ±×¶û ÄÝ·¹¿À½º¡¦ÁßÇü SUV ¸Â´ë°á °á°ú´Â? (2024-09-20)
Ç×°ø¿ìÁÖ»ê¾÷ ¿ÀÇÂÀ̳뺣ÀÌ¼Ç ÇÁ·Î±×·¥ ½ºÅ¸Æ®¾÷ ¸ðÁý (2023-10-22)
°æ±âµµ¡¤Çѱ¹»ê¾÷±â¼ú½ÃÇè¿ø¡¤Çѱ¹È­Çבּ¸¿ø ä¿ë (2025-08-06)
¡®³ª´Â SOLO¡¯ ¸íÀÛ ¼±¹°ÇÏ´Â ¼Ö·Î³²µéÀÇ ¡®Ã¹ÀÎ»ó ¼±ÅᯠºÎȰ (2025-07-09)
½ÅÇÑÅõÀÚÁõ±Ç, ³ª½º´Ú »óÀå»ç ¾Ëº¸Å×Å© ÅõÀÚ È¸¼ö ¿Ï·á (2025-06-25)
Perma-Pipe International Holdings, Inc., announces new proje... (2025-04-23)
MultiBank Group Named ¡®Best Prime Trading Broker¡¯ at Smart... (2025-03-12)
¿£Ä«´åÄÄ, BMW ÁõÁ¤ À̺¥Æ® ÁøÇà (2025-03-05)
º¯¿ì¼®, ÇÁ¶ó´Ù ÆÐ¼Ç¼î Âü¼® Â÷ Ãâ±¹ (2025-02-26)
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vac... (2024-12-25)
BNKºÎ»êÀºÇà, ±³À° Ä¿¹Â´ÏƼ ¼­ºñ½º ¡®¸ð¶ô¡¯ Ãâ½Ã (2024-12-18)
Çö´ëÂ÷, 2025 ¾ÆÀÌ¿À´Ð 5 N Ãâ½Ã (2024-09-25)
¿¡³ì, ¡®Â𵿻ý¡¯ ¸¶¸®¾Æ ¸¸³ª Á¡¼º¼úÁý ¹æ¹®... ¡®°áÈ¥¿î¡¯ ¾ð... (2024-08-28)
Zebec Announces Migration to ZBCN and Favorable Token Split ... (2024-04-17)
´õÁ¸ºñÁî¿Â, ÃÖ´ëÁÖÁÖ ¡®´õÁ¸È¦µù½º¡¯ Èí¼öÇÕº´ (2023-10-25)
Moxa, Â÷¼¼´ë x86 »ê¾÷¿ë ÄÄÇ»ÅÍ Ãâ½Ã (2024-03-11)
       [ÀÌÀü][1]....[777][778][779][780][781][782][783][784][785]...[4144][´ÙÀ½]

°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..